nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—Nephropathy toxic—Adefovir Dipivoxil—hepatitis B	0.0241	0.0241	CcSEcCtD
Ibandronate—Fracture—Adefovir Dipivoxil—hepatitis B	0.0238	0.0238	CcSEcCtD
Ibandronate—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.0238	0.0238	CcSEcCtD
Ibandronate—Multiple fractures—Adefovir Dipivoxil—hepatitis B	0.0238	0.0238	CcSEcCtD
Ibandronate—Influenza-like symptoms—Telbivudine—hepatitis B	0.0163	0.0163	CcSEcCtD
Ibandronate—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0145	0.0145	CcSEcCtD
Ibandronate—Bone pain—Adefovir Dipivoxil—hepatitis B	0.0144	0.0144	CcSEcCtD
Ibandronate—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.013	0.013	CcSEcCtD
Ibandronate—Musculoskeletal pain—Telbivudine—hepatitis B	0.0118	0.0118	CcSEcCtD
Ibandronate—Influenza like illness—Telbivudine—hepatitis B	0.0113	0.0113	CcSEcCtD
Ibandronate—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.0105	0.0105	CcSEcCtD
Ibandronate—Blood creatinine increased—Entecavir—hepatitis B	0.00964	0.00964	CcSEcCtD
Ibandronate—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0094	0.0094	CcSEcCtD
Ibandronate—Abdominal pain upper—Entecavir—hepatitis B	0.0094	0.0094	CcSEcCtD
Ibandronate—Throat sore—Lamivudine—hepatitis B	0.0091	0.0091	CcSEcCtD
Ibandronate—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.00902	0.00902	CcSEcCtD
Ibandronate—Renal impairment—Telbivudine—hepatitis B	0.00888	0.00888	CcSEcCtD
Ibandronate—Pain in extremity—Telbivudine—hepatitis B	0.00845	0.00845	CcSEcCtD
Ibandronate—Migraine—Telbivudine—hepatitis B	0.00832	0.00832	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Entecavir—hepatitis B	0.00826	0.00826	CcSEcCtD
Ibandronate—Blood disorder—Lamivudine—hepatitis B	0.00785	0.00785	CcSEcCtD
Ibandronate—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00785	0.00785	CcSEcCtD
Ibandronate—Renal failure—Entecavir—hepatitis B	0.00779	0.00779	CcSEcCtD
Ibandronate—Abdominal pain upper—Telbivudine—hepatitis B	0.00772	0.00772	CcSEcCtD
Ibandronate—Cramp muscle—Telbivudine—hepatitis B	0.00761	0.00761	CcSEcCtD
Ibandronate—Renal failure—Adefovir Dipivoxil—hepatitis B	0.0076	0.0076	CcSEcCtD
Ibandronate—Nasopharyngitis—Telbivudine—hepatitis B	0.00756	0.00756	CcSEcCtD
Ibandronate—Hepatobiliary disease—Entecavir—hepatitis B	0.0075	0.0075	CcSEcCtD
Ibandronate—Gastritis—Telbivudine—hepatitis B	0.00748	0.00748	CcSEcCtD
Ibandronate—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00731	0.00731	CcSEcCtD
Ibandronate—Influenza—Telbivudine—hepatitis B	0.0073	0.0073	CcSEcCtD
Ibandronate—Oropharyngeal pain—Lamivudine—hepatitis B	0.00721	0.00721	CcSEcCtD
Ibandronate—Oedema peripheral—Entecavir—hepatitis B	0.00701	0.00701	CcSEcCtD
Ibandronate—Abdominal discomfort—Telbivudine—hepatitis B	0.007	0.007	CcSEcCtD
Ibandronate—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00694	0.00694	CcSEcCtD
Ibandronate—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00689	0.00689	CcSEcCtD
Ibandronate—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00686	0.00686	CcSEcCtD
Ibandronate—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00682	0.00682	CcSEcCtD
Ibandronate—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00681	0.00681	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00679	0.00679	CcSEcCtD
Ibandronate—Inflammation—Lamivudine—hepatitis B	0.00676	0.00676	CcSEcCtD
Ibandronate—Musculoskeletal pain—Lamivudine—hepatitis B	0.00664	0.00664	CcSEcCtD
Ibandronate—Immune system disorder—Entecavir—hepatitis B	0.00643	0.00643	CcSEcCtD
Ibandronate—Renal failure—Telbivudine—hepatitis B	0.0064	0.0064	CcSEcCtD
Ibandronate—Alopecia—Entecavir—hepatitis B	0.00629	0.00629	CcSEcCtD
Ibandronate—Mental disorder—Entecavir—hepatitis B	0.00623	0.00623	CcSEcCtD
Ibandronate—Malnutrition—Entecavir—hepatitis B	0.00619	0.00619	CcSEcCtD
Ibandronate—Hepatobiliary disease—Telbivudine—hepatitis B	0.00616	0.00616	CcSEcCtD
Ibandronate—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00604	0.00604	CcSEcCtD
Ibandronate—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00596	0.00596	CcSEcCtD
Ibandronate—Mouth ulceration—Lamivudine—hepatitis B	0.00593	0.00593	CcSEcCtD
Ibandronate—Back pain—Adefovir Dipivoxil—hepatitis B	0.00585	0.00585	CcSEcCtD
Ibandronate—Pharyngitis—Telbivudine—hepatitis B	0.0058	0.0058	CcSEcCtD
Ibandronate—Connective tissue disorder—Telbivudine—hepatitis B	0.00574	0.00574	CcSEcCtD
Ibandronate—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00559	0.00559	CcSEcCtD
Ibandronate—Sleep disorder—Lamivudine—hepatitis B	0.0055	0.0055	CcSEcCtD
Ibandronate—Gastroenteritis—Lamivudine—hepatitis B	0.00537	0.00537	CcSEcCtD
Ibandronate—Deafness—Lamivudine—hepatitis B	0.00532	0.00532	CcSEcCtD
Ibandronate—Mediastinal disorder—Telbivudine—hepatitis B	0.00527	0.00527	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00524	0.00524	CcSEcCtD
Ibandronate—Injury—Lamivudine—hepatitis B	0.00518	0.00518	CcSEcCtD
Ibandronate—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00515	0.00515	CcSEcCtD
Ibandronate—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00515	0.00515	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00511	0.00511	CcSEcCtD
Ibandronate—Malnutrition—Telbivudine—hepatitis B	0.00509	0.00509	CcSEcCtD
Ibandronate—Anaphylactic shock—Entecavir—hepatitis B	0.00506	0.00506	CcSEcCtD
Ibandronate—Infection—Entecavir—hepatitis B	0.00502	0.00502	CcSEcCtD
Ibandronate—Renal impairment—Lamivudine—hepatitis B	0.005	0.005	CcSEcCtD
Ibandronate—Thirst—Lamivudine—hepatitis B	0.005	0.005	CcSEcCtD
Ibandronate—Dysgeusia—Telbivudine—hepatitis B	0.00498	0.00498	CcSEcCtD
Ibandronate—Nervous system disorder—Entecavir—hepatitis B	0.00496	0.00496	CcSEcCtD
Ibandronate—Back pain—Telbivudine—hepatitis B	0.00492	0.00492	CcSEcCtD
Ibandronate—Skin disorder—Entecavir—hepatitis B	0.00491	0.00491	CcSEcCtD
Ibandronate—Muscle spasms—Telbivudine—hepatitis B	0.00489	0.00489	CcSEcCtD
Ibandronate—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00484	0.00484	CcSEcCtD
Ibandronate—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00479	0.00479	CcSEcCtD
Ibandronate—Ill-defined disorder—Telbivudine—hepatitis B	0.00472	0.00472	CcSEcCtD
Ibandronate—Migraine—Lamivudine—hepatitis B	0.00469	0.00469	CcSEcCtD
Ibandronate—Malaise—Telbivudine—hepatitis B	0.00459	0.00459	CcSEcCtD
Ibandronate—Insomnia—Entecavir—hepatitis B	0.00457	0.00457	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00449	0.00449	CcSEcCtD
Ibandronate—Dyspepsia—Entecavir—hepatitis B	0.00445	0.00445	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Entecavir—hepatitis B	0.00436	0.00436	CcSEcCtD
Ibandronate—Fatigue—Entecavir—hepatitis B	0.00436	0.00436	CcSEcCtD
Ibandronate—Abdominal pain upper—Lamivudine—hepatitis B	0.00435	0.00435	CcSEcCtD
Ibandronate—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00434	0.00434	CcSEcCtD
Ibandronate—Myalgia—Telbivudine—hepatitis B	0.00433	0.00433	CcSEcCtD
Ibandronate—Arthralgia—Telbivudine—hepatitis B	0.00433	0.00433	CcSEcCtD
Ibandronate—Chest pain—Telbivudine—hepatitis B	0.00433	0.00433	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0043	0.0043	CcSEcCtD
Ibandronate—Cramp muscle—Lamivudine—hepatitis B	0.00429	0.00429	CcSEcCtD
Ibandronate—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00429	0.00429	CcSEcCtD
Ibandronate—Discomfort—Telbivudine—hepatitis B	0.00428	0.00428	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00426	0.00426	CcSEcCtD
Ibandronate—Nasopharyngitis—Lamivudine—hepatitis B	0.00426	0.00426	CcSEcCtD
Ibandronate—Gastrointestinal pain—Entecavir—hepatitis B	0.00413	0.00413	CcSEcCtD
Ibandronate—Dysphagia—Lamivudine—hepatitis B	0.00412	0.00412	CcSEcCtD
Ibandronate—Influenza—Lamivudine—hepatitis B	0.00412	0.00412	CcSEcCtD
Ibandronate—Nervous system disorder—Telbivudine—hepatitis B	0.00407	0.00407	CcSEcCtD
Ibandronate—Skin disorder—Telbivudine—hepatitis B	0.00403	0.00403	CcSEcCtD
Ibandronate—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00403	0.00403	CcSEcCtD
Ibandronate—Abdominal pain—Entecavir—hepatitis B	0.004	0.004	CcSEcCtD
Ibandronate—Body temperature increased—Entecavir—hepatitis B	0.004	0.004	CcSEcCtD
Ibandronate—Bronchitis—Lamivudine—hepatitis B	0.00396	0.00396	CcSEcCtD
Ibandronate—Abdominal discomfort—Lamivudine—hepatitis B	0.00395	0.00395	CcSEcCtD
Ibandronate—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.0039	0.0039	CcSEcCtD
Ibandronate—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.0039	0.0039	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00378	0.00378	CcSEcCtD
Ibandronate—Insomnia—Telbivudine—hepatitis B	0.00376	0.00376	CcSEcCtD
Ibandronate—Paraesthesia—Telbivudine—hepatitis B	0.00373	0.00373	CcSEcCtD
Ibandronate—Depression—Lamivudine—hepatitis B	0.00366	0.00366	CcSEcCtD
Ibandronate—Dyspepsia—Telbivudine—hepatitis B	0.00366	0.00366	CcSEcCtD
Ibandronate—Asthenia—Entecavir—hepatitis B	0.00363	0.00363	CcSEcCtD
Ibandronate—Renal failure—Lamivudine—hepatitis B	0.00361	0.00361	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00359	0.00359	CcSEcCtD
Ibandronate—Fatigue—Telbivudine—hepatitis B	0.00358	0.00358	CcSEcCtD
Ibandronate—Stomatitis—Lamivudine—hepatitis B	0.00358	0.00358	CcSEcCtD
Ibandronate—Pain—Telbivudine—hepatitis B	0.00355	0.00355	CcSEcCtD
Ibandronate—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00354	0.00354	CcSEcCtD
Ibandronate—Sweating—Lamivudine—hepatitis B	0.00352	0.00352	CcSEcCtD
Ibandronate—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00349	0.00349	CcSEcCtD
Ibandronate—Hepatobiliary disease—Lamivudine—hepatitis B	0.00347	0.00347	CcSEcCtD
Ibandronate—Diarrhoea—Entecavir—hepatitis B	0.00346	0.00346	CcSEcCtD
Ibandronate—Feeling abnormal—Telbivudine—hepatitis B	0.00342	0.00342	CcSEcCtD
Ibandronate—Gastrointestinal pain—Telbivudine—hepatitis B	0.0034	0.0034	CcSEcCtD
Ibandronate—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00338	0.00338	CcSEcCtD
Ibandronate—Dizziness—Entecavir—hepatitis B	0.00334	0.00334	CcSEcCtD
Ibandronate—Abdominal pain—Telbivudine—hepatitis B	0.00328	0.00328	CcSEcCtD
Ibandronate—Body temperature increased—Telbivudine—hepatitis B	0.00328	0.00328	CcSEcCtD
Ibandronate—Pharyngitis—Lamivudine—hepatitis B	0.00327	0.00327	CcSEcCtD
Ibandronate—Connective tissue disorder—Lamivudine—hepatitis B	0.00324	0.00324	CcSEcCtD
Ibandronate—Vomiting—Entecavir—hepatitis B	0.00321	0.00321	CcSEcCtD
Ibandronate—Rash—Entecavir—hepatitis B	0.00319	0.00319	CcSEcCtD
Ibandronate—Dermatitis—Entecavir—hepatitis B	0.00318	0.00318	CcSEcCtD
Ibandronate—Headache—Entecavir—hepatitis B	0.00317	0.00317	CcSEcCtD
Ibandronate—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00314	0.00314	CcSEcCtD
Ibandronate—Rash—Adefovir Dipivoxil—hepatitis B	0.00311	0.00311	CcSEcCtD
Ibandronate—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00311	0.00311	CcSEcCtD
Ibandronate—Headache—Adefovir Dipivoxil—hepatitis B	0.00309	0.00309	CcSEcCtD
Ibandronate—Nausea—Entecavir—hepatitis B	0.003	0.003	CcSEcCtD
Ibandronate—Asthenia—Telbivudine—hepatitis B	0.00298	0.00298	CcSEcCtD
Ibandronate—Immune system disorder—Lamivudine—hepatitis B	0.00298	0.00298	CcSEcCtD
Ibandronate—Mediastinal disorder—Lamivudine—hepatitis B	0.00297	0.00297	CcSEcCtD
Ibandronate—Chills—Lamivudine—hepatitis B	0.00296	0.00296	CcSEcCtD
Ibandronate—Pruritus—Telbivudine—hepatitis B	0.00294	0.00294	CcSEcCtD
Ibandronate—Nausea—Adefovir Dipivoxil—hepatitis B	0.00293	0.00293	CcSEcCtD
Ibandronate—Alopecia—Lamivudine—hepatitis B	0.00291	0.00291	CcSEcCtD
Ibandronate—Malnutrition—Lamivudine—hepatitis B	0.00287	0.00287	CcSEcCtD
Ibandronate—Erythema—Lamivudine—hepatitis B	0.00287	0.00287	CcSEcCtD
Ibandronate—Diarrhoea—Telbivudine—hepatitis B	0.00284	0.00284	CcSEcCtD
Ibandronate—Flatulence—Lamivudine—hepatitis B	0.00283	0.00283	CcSEcCtD
Ibandronate—Dysgeusia—Lamivudine—hepatitis B	0.00281	0.00281	CcSEcCtD
Ibandronate—Back pain—Lamivudine—hepatitis B	0.00277	0.00277	CcSEcCtD
Ibandronate—Muscle spasms—Lamivudine—hepatitis B	0.00276	0.00276	CcSEcCtD
Ibandronate—Dizziness—Telbivudine—hepatitis B	0.00275	0.00275	CcSEcCtD
Ibandronate—Ill-defined disorder—Lamivudine—hepatitis B	0.00266	0.00266	CcSEcCtD
Ibandronate—Anaemia—Lamivudine—hepatitis B	0.00265	0.00265	CcSEcCtD
Ibandronate—Vomiting—Telbivudine—hepatitis B	0.00264	0.00264	CcSEcCtD
Ibandronate—Angioedema—Lamivudine—hepatitis B	0.00262	0.00262	CcSEcCtD
Ibandronate—Rash—Telbivudine—hepatitis B	0.00262	0.00262	CcSEcCtD
Ibandronate—Dermatitis—Telbivudine—hepatitis B	0.00262	0.00262	CcSEcCtD
Ibandronate—Headache—Telbivudine—hepatitis B	0.0026	0.0026	CcSEcCtD
Ibandronate—Malaise—Lamivudine—hepatitis B	0.00259	0.00259	CcSEcCtD
Ibandronate—Vertigo—Lamivudine—hepatitis B	0.00258	0.00258	CcSEcCtD
Ibandronate—Nausea—Telbivudine—hepatitis B	0.00247	0.00247	CcSEcCtD
Ibandronate—Arthralgia—Lamivudine—hepatitis B	0.00244	0.00244	CcSEcCtD
Ibandronate—Chest pain—Lamivudine—hepatitis B	0.00244	0.00244	CcSEcCtD
Ibandronate—Myalgia—Lamivudine—hepatitis B	0.00244	0.00244	CcSEcCtD
Ibandronate—Anxiety—Lamivudine—hepatitis B	0.00243	0.00243	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00242	0.00242	CcSEcCtD
Ibandronate—Discomfort—Lamivudine—hepatitis B	0.00241	0.00241	CcSEcCtD
Ibandronate—Dry mouth—Lamivudine—hepatitis B	0.00239	0.00239	CcSEcCtD
Ibandronate—Anaphylactic shock—Lamivudine—hepatitis B	0.00234	0.00234	CcSEcCtD
Ibandronate—Infection—Lamivudine—hepatitis B	0.00233	0.00233	CcSEcCtD
Ibandronate—Shock—Lamivudine—hepatitis B	0.0023	0.0023	CcSEcCtD
Ibandronate—Nervous system disorder—Lamivudine—hepatitis B	0.0023	0.0023	CcSEcCtD
Ibandronate—Skin disorder—Lamivudine—hepatitis B	0.00227	0.00227	CcSEcCtD
Ibandronate—Hyperhidrosis—Lamivudine—hepatitis B	0.00226	0.00226	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00213	0.00213	CcSEcCtD
Ibandronate—Insomnia—Lamivudine—hepatitis B	0.00212	0.00212	CcSEcCtD
Ibandronate—Paraesthesia—Lamivudine—hepatitis B	0.0021	0.0021	CcSEcCtD
Ibandronate—Dyspepsia—Lamivudine—hepatitis B	0.00206	0.00206	CcSEcCtD
Ibandronate—Decreased appetite—Lamivudine—hepatitis B	0.00203	0.00203	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00202	0.00202	CcSEcCtD
Ibandronate—Fatigue—Lamivudine—hepatitis B	0.00202	0.00202	CcSEcCtD
Ibandronate—Constipation—Lamivudine—hepatitis B	0.002	0.002	CcSEcCtD
Ibandronate—Pain—Lamivudine—hepatitis B	0.002	0.002	CcSEcCtD
Ibandronate—Feeling abnormal—Lamivudine—hepatitis B	0.00193	0.00193	CcSEcCtD
Ibandronate—Gastrointestinal pain—Lamivudine—hepatitis B	0.00191	0.00191	CcSEcCtD
Ibandronate—Urticaria—Lamivudine—hepatitis B	0.00186	0.00186	CcSEcCtD
Ibandronate—Body temperature increased—Lamivudine—hepatitis B	0.00185	0.00185	CcSEcCtD
Ibandronate—Abdominal pain—Lamivudine—hepatitis B	0.00185	0.00185	CcSEcCtD
Ibandronate—Hypersensitivity—Lamivudine—hepatitis B	0.00172	0.00172	CcSEcCtD
Ibandronate—Asthenia—Lamivudine—hepatitis B	0.00168	0.00168	CcSEcCtD
Ibandronate—Pruritus—Lamivudine—hepatitis B	0.00166	0.00166	CcSEcCtD
Ibandronate—Diarrhoea—Lamivudine—hepatitis B	0.0016	0.0016	CcSEcCtD
Ibandronate—Dizziness—Lamivudine—hepatitis B	0.00155	0.00155	CcSEcCtD
Ibandronate—Vomiting—Lamivudine—hepatitis B	0.00149	0.00149	CcSEcCtD
Ibandronate—Rash—Lamivudine—hepatitis B	0.00148	0.00148	CcSEcCtD
Ibandronate—Dermatitis—Lamivudine—hepatitis B	0.00147	0.00147	CcSEcCtD
Ibandronate—Headache—Lamivudine—hepatitis B	0.00147	0.00147	CcSEcCtD
Ibandronate—Nausea—Lamivudine—hepatitis B	0.00139	0.00139	CcSEcCtD
